A potential platform of combining sialic acid derivative-modified paclitaxel cationic liposomes with antibody–drug conjugates inspires robust tumor-specific immunological memory in solid tumors

The combined application of SA-modified cationic liposomes with ADCs induces complete tumor regression and inspires robust tumor-specific immunological memory.